![Sheila Gujrathi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sheila Gujrathi
Presidente presso
PROCESSA PHARMACEUTICALS, INC.
Patrimonio netto: 4 M $ in data 30/09/2026
Profilo
Sheila Gujrathi è un uomo d'affari che ha fondato Gossamer Bio, Inc. e che è stato a capo di 5 diverse aziende. La dott.ssa Gujrathi occupa la posizione di presidente di Turning Point Therapeutics, Inc., presidente di ADARx Pharmaceuticals, Inc., amministratore delegato di GB001, Inc. e amministratore delegato di GB006, Inc. Sheila Gujrathi è anche nel consiglio di Janux Therapeutics, Inc. In passato è stata presidente, amministratore delegato e direttore di Gossamer Bio, Inc., vicepresidente del gruppo di sviluppo clinico globale di Bristol Myers Squibb Co. e direttore medico di Receptos LLC (una filiale di Bristol Myers Squibb Co.) e capo del team di franchising di Genentech, Inc. Ha ricevuto un dottorato e una laurea presso la Northwestern University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/02/2026 | 112.639 ( 0,19% ) | 2 M $ | 30/09/2026 | |
| 07/08/2026 | 90.160 ( 0,28% ) | 2 M $ | 30/09/2026 |
Posizioni attive di Sheila Gujrathi
| Società | Posizione | Inizio |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 18/03/2021 |
| PROCESSA PHARMACEUTICALS, INC. | Presidente | 28/10/2026 |
| BLOSSOMHILL THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/05/2026 |
| BOLT BIOTHERAPEUTICS, INC. | Direttore/Membro del Consiglio | 23/10/2026 |
Generian Pharmaceuticals, Inc.
 Generian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops gain-of-function drugs that activate key cellular networks | Presidente | 01/05/2023 |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Consulente / Consigliere | - |
GB006, Inc.
 GB006, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Amministratore Delegato | - |
Precedenti posizioni note di Sheila Gujrathi
| Società | Posizione | Fine |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Presidente | 04/03/2026 |
| ADARX PHARMACEUTICALS, INC. | Presidente | 01/01/2025 |
| ░░░░░░░ ░░░ ░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░ ░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Sheila Gujrathi
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
73
Relazioni di 1° grado
20
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 20 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Processa Pharmaceuticals, Inc.
 Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
GB001, Inc.
 GB001, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
GB006, Inc.
GB006, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Generian Pharmaceuticals, Inc.
Generian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops gain-of-function drugs that activate key cellular networks | Health Technology |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops siRNA therapeutics to treat diseases | Health Technology |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Health Technology |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
